<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03920761</url>
  </required_header>
  <id_info>
    <org_study_id>ETNA</org_study_id>
    <nct_id>NCT03920761</nct_id>
  </id_info>
  <brief_title>Evaluation of Technologies for Neonates in Africa</brief_title>
  <acronym>ETNA</acronym>
  <official_title>Evaluation of Technologies for Neonates in Africa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Save the Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>EarlySense Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>SWICA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bill and Melinda Gates Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Save the Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a diagnostic accuracy evaluation and clinical feasibility study of investigational&#xD;
      devices (EarlySense and ANNE systems) in a neonatal high dependency unit (nHDU) in a private&#xD;
      teaching hospital and a government maternity hospital in Nairobi, Kenya. Neonates who are&#xD;
      admitted for routine observation and care will be enrolled.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To further reduce neonatal mortality rate in low resource settings (LRS) in Africa, research&#xD;
      is needed to develop and optimize innovations in neonatal care, specifically technologies&#xD;
      that are low cost, operator-independent, and highly efficient. The purpose of this study is&#xD;
      to produce information and data regarding the performance of two existing multiparameter&#xD;
      continuous physiological monitoring devices developed by device developers, EarlySense and&#xD;
      Sonica. The clinical trial is intended to provide evidence to establish whether these&#xD;
      investigational devices can reliably and accurately measure vital signs in neonates (when&#xD;
      compared to verified reference devices) and to assess the feasibility, usability and&#xD;
      acceptability of these devices for use in neonates in a LRS in Africa.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 27, 2019</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the accuracy the investigational devices: Agreement of the relevant measurement</measure>
    <time_frame>Measurements will be collected at one minute intervals for a minimum of 1 hour</time_frame>
    <description>Agreement of the relevant measurement parameters of interest between the investigational device and the reference device(s) at each observation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine the clinical feasibility of the investigational devices: Agreement of clinical event detection</measure>
    <time_frame>Measurements collected at one minute intervals for a minimum of 1 hour</time_frame>
    <description>Agreement of clinical event detection between the investigational device and the reference device(s) at each observation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess the feasibility, usability and acceptability of the investigational device: questionnaire</measure>
    <time_frame>One 30 minute in-depth interview</time_frame>
    <description>Qualitative questionnaire</description>
  </primary_outcome>
  <enrollment type="Actual">575</enrollment>
  <condition>Neonatal Physiology</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EarlySense Insight system</intervention_name>
    <description>a small piezoelectric sensor pad that can be placed under the mattress and provide contact-free monitoring by measuring and recording a patient's vital signs and motion parameters</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Advanced Neonatal Epidermal System</intervention_name>
    <description>a system of neonatal non-invasive adhesive sensors. Sensors are attached directly on the patient's body and are capable of continuously measuring and recording heart rate, respiratory rate, oxygen saturation, and skin temperature.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Neonates enrolled in the study will be representative of the ethnic demographics in&#xD;
        Nairobi, Kenya. Both female and male neonates will be enrolled.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female neonate, corrected age of â‰¤ 28 days.&#xD;
&#xD;
          2. Willingness and ability of neonate's caregiver to provide informed consent and to be&#xD;
             available for follow-up for the planned duration of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Receiving mechanical ventilation or continuous positive airway pressure (CPAP).&#xD;
&#xD;
          2. Skin abnormalities in the nasopharynx and/or oropharynx.&#xD;
&#xD;
          3. Contraindication to application of skin sensors.&#xD;
&#xD;
          4. Known arrhythmia.&#xD;
&#xD;
          5. Presence of a congenital abnormality requiring major surgical intervention.&#xD;
&#xD;
          6. Any medical or psychosocial condition or circumstance that, in the opinion of the&#xD;
             investigators, would interfere with the conduct of the study or for which study&#xD;
             participation might jeopardize the neonate's health.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Ansermino</last_name>
    <role>Principal Investigator</role>
    <affiliation>BC Children's Hospital, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aga Khan University Hospital, Nairobi</name>
      <address>
        <city>Nairobi</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pumwani Maternity Hospital</name>
      <address>
        <city>Nairobi</city>
        <country>Kenya</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>If in the future data sharing is needed, the study will establish appropriate data transfer agreements with other researchers and only de-identified data will be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

